BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31155559)

  • 1. Ease of Taking and Palatability of Fixed-Dose Orally Disintegrating Mitiglinide/Voglibose Tablets.
    Sotoyama M; Uchida S; Kamiya C; Tanaka S; Kashiwagura Y; Hakamata A; Odagiri K; Inui N; Watanabe H; Namiki N
    Chem Pharm Bull (Tokyo); 2019; 67(6):540-545. PubMed ID: 31155559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of Cocoa Powder-Containing Orally Disintegrating Tablets of Rebamipide (Rebamipide Chocolet) and Evaluation of Their Clinical Palatability.
    Takano H; Uchida S; Kashiwagura Y; Tanaka S; Hakamata A; Odagiri K; Inui N; Watanabe H; Namiki N
    Chem Pharm Bull (Tokyo); 2019; 67(2):112-119. PubMed ID: 30713270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of granule properties on rough mouth feel and palatability of orally disintegrating tablets.
    Kimura S; Uchida S; Kanada K; Namiki N
    Int J Pharm; 2015 Apr; 484(1-2):156-62. PubMed ID: 25681720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the ease of taking mini-tablets compared with other tablet formulations in healthy volunteers.
    Hayakawa Y; Uchida S; Namiki N
    Eur J Pharm Sci; 2016 Mar; 84():157-61. PubMed ID: 26739235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method.
    Abdelmonem R; Abdellatif MM; Al-Samadi IEI; El-Nabarawi MA
    Drug Des Devel Ther; 2021; 15():4383-4402. PubMed ID: 34690500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citric Acid Suppresses the Bitter Taste of Olopatadine Hydrochloride Orally Disintegrating Tablets.
    Sotoyama M; Uchida S; Tanaka S; Hakamata A; Odagiri K; Inui N; Watanabe H; Namiki N
    Biol Pharm Bull; 2017; 40(4):451-457. PubMed ID: 28381800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative palatability of orally disintegrating tablets (ODTs) of Praziquantel (L-PZQ and Rac-PZQ) versus current PZQ tablet in African children: A randomized, single-blind, crossover study.
    Mahende MK; Huber E; Kourany-Lefoll E; Ali A; Hayward B; Bezuidenhout D; Bagchus W; Kabanywanyi AM
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0007370. PubMed ID: 34106922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of unpleasant taste-masked pioglitazone orally disintegrating tablets.
    Nakano Y; Maeda A; Uchida S; Namiki N
    Int J Pharm; 2013 Mar; 446(1-2):160-5. PubMed ID: 23419665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of palatability of 10 commercial amlodipine orally disintegrating tablets by gustatory sensation testing, OD-mate as a new disintegration apparatus and the artificial taste sensor.
    Uchida T; Yoshida M; Hazekawa M; Haraguchi T; Furuno H; Teraoka M; Ikezaki H
    J Pharm Pharmacol; 2013 Sep; 65(9):1312-20. PubMed ID: 23927469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
    Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
    Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination effect of physical and gustatory taste masking for propiverine hydrochloride orally disintegrating tablets on palatability.
    Matsui R; Uchida S; Namiki N
    Biol Pharm Bull; 2015; 38(1):17-22. PubMed ID: 25744453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fixed-dose combination orally disintegrating tablets to treat cardiovascular disease: formulation, in vitro characterization and physiologically based pharmacokinetic modeling to assess bioavailability.
    Dennison TJ; Smith JC; Badhan RK; Mohammed AR
    Drug Des Devel Ther; 2017; 11():811-826. PubMed ID: 28352156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taste-masking effect of physical and organoleptic methods on peppermint-scented orally disintegrating tablet of famotidine based on suspension spray-coating method.
    Sugiura T; Uchida S; Namiki N
    Chem Pharm Bull (Tokyo); 2012; 60(3):315-9. PubMed ID: 22382410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and evaluation of bitter taste-masked orally disintegrating tablets of high memantine hydrochloride loaded granules coated with polymer via layering technique.
    Kadota K; Terada H; Fujimoto A; Nogami S; Uchiyama H; Tozuka Y
    Int J Pharm; 2021 Jul; 604():120725. PubMed ID: 34029663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin.
    Ge Z; Yang M; Wang Y; Shan L; Gao C
    Drug Dev Ind Pharm; 2015 Jun; 41(6):934-41. PubMed ID: 24785576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing the disintegration and texture-related palatability predictions for orodispersible tablets using an instrumental tool coupled with multivariate analysis: Focus on process variables and analysis settings.
    Iovanov R; Cornilă A; Bogdan C; Hales D; Tomuță I; Achim M; Tăut A; Iman N; Casian T; Iurian S
    Eur J Pharm Sci; 2024 Jul; 198():106801. PubMed ID: 38754594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
    Tafere C; Yilma Z; Abrha S; Yehualaw A
    PLoS One; 2021; 16(3):e0246648. PubMed ID: 33725014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.
    Liu Y; Li P; Qian R; Sun T; Fang F; Wang Z; Ke X; Xu B
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1317-1327. PubMed ID: 29521132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microwave-Assisted Development of Orally Disintegrating Tablets by Direct Compression.
    Kande KV; Kotak DJ; Degani MS; Kirsanov D; Legin A; Devarajan PV
    AAPS PharmSciTech; 2017 Aug; 18(6):2055-2066. PubMed ID: 27995465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of active ingredients on the swelling properties of orally disintegrating tablets prepared by microwave treatment.
    Sano S; Iwao Y; Kimura S; Noguchi S; Itai S
    Int J Pharm; 2014 Jul; 468(1-2):234-42. PubMed ID: 24709215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.